Wednesday, February 08, 2017 8:04:51 AM
Oxycodone looks no more an hot topic, patent secured is a non-event, Mallinkdroct deal ...just marginal, focalin residual doses...already expected.
I won't sell a single share, since I am one of the last "believer" in IPCI growth prospects.
But I respect everybody analysis and opinion, this is just my voice on the fact the IPCI looks like just not being in the biotech realm of investing.
biotech means risk; with risk comes reward or failure.
Many here are analysing IPCI looking for safe aspects, for reassuring elements, in a word...for certainty.
instead IPCI does belong to the opposite kind: risky, uncertain (even if somewhat limited). But you keep on reading of people waiting to buy or increase until major transaformation occurs. And maybe IPCI is not going to explode, never, but I just don't why someone invests into a biotech, expecting all those characteristics that usually you don't fine in ultra small cap biotechs.
I just don't get it.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM